BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025 - 2026)

BioAge Labs (BIOA) reported Change in Acquisitions & Divestments of $33.5 million for Q1 2026, up 28.8% sequentially from $26.0 million in Q4 2025.

BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

BioAge Labs (BIOA) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $33.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $33.5 million; the trailing twelve-month figure through Mar 2026 stood at $93.7 million (changed N/A YoY), and the FY2025 full-year result was $60.2 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments improved to $33.5 million in Q1 2026, from $26.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $33.5 million in Q1 2026 to a low of $8.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 BioAge Labs 930.32 Mn 930.32 Mn -10.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.49 Mn
Mar 31, 2026 33.49 Mn
Dec 31, 2025 26.00 Mn
Dec 31, 2025 26.00 Mn
Sep 30, 2025 25.75 Mn
Sep 30, 2025 25.75 Mn
Jun 30, 2025 8.50 Mn
Jun 30, 2025 8.50 Mn